The Recall Desk
CriticalFDA (Drugs)·D-1398-2019·Announced 2019-06-19

Heritage Pharmaceuticals Recalls Amikacin Sulfate Injection Due to Microbial Growth

Heritage Pharmaceuticals is recalling Amikacin Sulfate Injection vials because microbial growth was detected in a sub-lot. The affected product is distributed nationwide in the USA.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The FDA has classified this recall as Class I, which meets the rubric criteria for a Critical severity score.

Plain-English summary

Heritage Pharmaceuticals, Inc. is recalling 14,960 vials of Amikacin Sulfate Injection, USP, 1 gram/4 mL (250 mg/mL). The recall is due to the detection of microbial growth in a sub-lot of the product. The affected lot number is VEAC025, with an expiration date of 10-2019.

The product is a prescription-only injection manufactured by Emcure Pharmaceuticals, Ltd. in India for Heritage Pharmaceuticals, Inc. It is distributed nationwide in the USA. The recall also notes that microbial growth was detected in a sub-lot of Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL).

Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class I, indicating a reasonable probability that use of the product may cause serious adverse health consequences or death.

The recalled product

Product
AMIKACIN SULFATE (AMIKACIN SULFATE)
Brand
AMIKACIN SULFATE

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot: VEAC025
  • EXP 10-2019

UPCs (2)

  • 0323155290325
  • 0323155290318

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Heritage Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →